Adaptive Integrated Stent Systems for Specialized Environments

The inventive concept integrates Z stents and braided stents to create adaptable systems for stenting in high-altitude, extreme weather, disaster relief, high-security, and remote off-grid locations.

The original Integrated Z and Wallstent patent addressed the need for stents in the venous system, particularly near the iliac-caval junction. However, these stents were not designed to operate in specialized environments with unique challenges, such as low oxygen levels, high pressure, or extreme weather conditions. The new inventive concept solves this problem by adapting the integrated stent system to these specific niches.

The new claims describe modified Z stents and braided stents that can operate in high-altitude environments with low oxygen levels, extreme weather conditions, disaster relief scenarios, high-security facilities, and remote off-grid locations. The Z stents are reinforced with additional struts, modified for low-oxygen environments, or made from high-strength, tamper-evident materials. The braided stents are designed for high-pressure resistance, coated with weather-resistant materials, treated with antimicrobial coatings, or equipped with RFID tracking devices. The stent systems can be powered by miniature, battery-powered actuators or designed for manual deployment.

The new claims introduce novel modifications to the original integrated stent system, including adaptations for specialized environments, which are not obvious from the original patent. The inventive step lies in the combination of these modifications to create stent systems that can operate effectively in these unique niches.

Alternative embodiments of the inventive concept could include using different materials, such as shape-memory alloys or biodegradable polymers, or incorporating additional features, such as sensors or drug-eluting coatings. Variations of the stent systems could be designed for specific medical conditions, such as deep vein thrombosis or pulmonary embolism.

The inventive concept has significant commercial potential in the medical device industry, particularly in the fields of interventional cardiology and vascular surgery. The target markets include hospitals, medical research institutions, and disaster relief organizations operating in specialized environments.